A prospective non-controlled cohort study evaluating the outcomes of artificial urinary sphincter implantation surgery (Robot-assisted, Laparoscopic, Open or other) in female patients for the treatment of stress urinary incontinence due to intrinsic sphincter deficiency.
The goal of the VENUS registry is to get insight into the clinical daily practice of artificial urinary sphincter (AUS) implantation surgeries and the short and long term follow-up outcomes e.g. efficacy, complications, quality of live, urodynamic parameters and sexual functioning within female patients with stress urinary incontinence (SUI) due to intrinsic sphincter deficiency (ISD).
The main interest will be the cure rate of AUS implantation surgeries, with cure rate defined as urinary continence with no pads used or use of 1 light security pad. A total of 150 patients will be recruited within three years, hereafter, patients will be followed until the end of the registry.
Due to the COVID-19 pandemic it has been challenging to recruit patients for the VENUS registry, because for most centres AUS implantation was considered non urgent and surgeries were postponed or halted.
Nevertheless, in the last few months the inclusion of patients has accelerated. More than 13 centres have now started recruitment and it is expected that this participation rate will now continue to increase as an additional nine centres are initiated and ready to start including patients, with a further five other centres in the initiation process or filing for ethical committee approval also.